U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7398173981Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy VolunteersCompletedNo Results AvailableReflux OesophagitisDrug: YF476https://ClinicalTrials.gov/show/NCT01597674
7398273982Bupropion & Cardio Birth Defect (Slone)CompletedNo Results AvailableDepressive DisorderDrug: Exposure to any bupropion during the first trimester|Drug: Exposure to bupropion alone during the first trimester|Other: Referent group: no exposure to any anti-depressant or anti-smoking drug during pregnancyhttps://ClinicalTrials.gov/show/NCT01597661
7398373983A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivirâ„¢CompletedNo Results AvailableInfection, Human Immunodeficiency Virus IDrug: Maraviroc|Drug: Combivir|Drug: GSK2838510https://ClinicalTrials.gov/show/NCT01597648
7398473984The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung InjuryCompletedNo Results AvailableLung Injury, AcuteDrug: Dose 1 GSK2586881|Drug: Dose 2 GSK2586881|Drug: Dose 3 GSK2586881|Drug: Dose 4 GSK2586881|Drug: Placebo (saline)https://ClinicalTrials.gov/show/NCT01597635
7398573985BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115RecruitingNo Results AvailableSystemic Lupus ErythematosusDrug: Belimumabhttps://ClinicalTrials.gov/show/NCT01597622
7398673986A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese SubjectsCompletedNo Results AvailableInsufficient InformationDrug: sibutramine|Other: sibutramine placebohttps://ClinicalTrials.gov/show/NCT01597609
7398773987A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Patients With Infantile-Onset Pompe Disease Who Have Never Been TreatedCompletedNo Results AvailablePompe Disease (Infantile-Onset)|Glycogen Storage Disease Type II (GSD II)|Glycogenosis 2|Acid Maltase DeficiencyBiological: alglucosidase alfa|Biological: alglucosidase alfahttps://ClinicalTrials.gov/show/NCT01597596
7398873988MobileMedMinder: A Networked Aide for Medication CompliancesCompletedNo Results AvailableHeart Failure, CongestiveBehavioral: Use of MobileMedMinderhttps://ClinicalTrials.gov/show/NCT01597583
7398973989Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC SystemTerminatedNo Results AvailableThe Patients Who Needed Hemostasis at the Puncture Site of Common Femoral Artety(CFA) Caused by Femoral Angiogram or Intervention After the Catheter RemovalDevice: Vascular Closure Devicehttps://ClinicalTrials.gov/show/NCT01597570
7399073990Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation TrialCompletedNo Results AvailableAtrial FibrillationDrug: Magnesium Sulfate|Other: Placebohttps://ClinicalTrials.gov/show/NCT01597557
7399173991Post-operative Voiding Dysfunction: the Preferred Method for CatheterizationRecruitingNo Results AvailableVoiding Dysfunction After Pelvic Organ Prolapse SurgeryProcedure: CISC instruction pre-operativelyhttps://ClinicalTrials.gov/show/NCT01597544
7399273992Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric BandingRecruitingNo Results AvailableType 2 Diabetes|Gastric BandingDrug: Liraglutide|Drug: Orlistat|Drug: Liraglutide + Orlistathttps://ClinicalTrials.gov/show/NCT01597531
7399373993Riluzole in Spinal Cord Injury StudyRecruitingNo Results AvailableSpinal Cord InjuryDrug: Riluzole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01597518
7399473994Study of CB-183,315 in Patients With Clostridium Difficile Associated DiarrheaCompletedNo Results AvailableClostridium Difficile InfectionDrug: CB-183,315|Drug: oral vancomycinhttps://ClinicalTrials.gov/show/NCT01597505
7399573995A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)Active, not recruitingNo Results AvailableSystemic Lupus ErythematosusBiological: Belimumab plus Early Vaccination|Biological: Belimumab plus Late Vaccinationhttps://ClinicalTrials.gov/show/NCT01597492
7399673996Efficacy of Peripheral Nerve Blocks in Rizarthrosis Ambulatory SurgeryRecruitingNo Results AvailableAmbulatory Rizarthrosis SurgeryDrug: Levobupivacainehttps://ClinicalTrials.gov/show/NCT01597479
7399773997Epidrum for Thoracic Epidural AnalgesiaRecruitingNo Results AvailablePainDevice: Epidural catheter placement|Procedure: Epidural catheter placementhttps://ClinicalTrials.gov/show/NCT01597466
7399873998NOR-SYS: The Norwegian Stroke in the Young StudyRecruitingNo Results AvailableDeath|Carotid Artery Disease|Cardiovascular Disease|Peripheral Artery DiseaseBehavioral: Lifestyle counselinghttps://ClinicalTrials.gov/show/NCT01597453
7399973999Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic AcidemiaTerminatedNo Results AvailablePropionic Acidemia (PA)|Methylmalonic Acidemia (MMA)Drug: N-carbamylglutamatehttps://ClinicalTrials.gov/show/NCT01597440
7400074000Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac SurgeryCompletedNo Results AvailableAnesthesiaDrug: Clonidine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01597427
7400174001Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1RecruitingNo Results AvailableElderly Metastatic Breast Cancer PopulationDrug: Pertuzumab + trastuzumab|Drug: Pertuzumab + trastuzumab + metronomic chemotherapyhttps://ClinicalTrials.gov/show/NCT01597414
7400274002A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell DiseaseCompletedNo Results AvailableAnemia, Sickle CellDrug: Aes-103|Drug: Aes-103|Drug: Aes-103|Drug: Aes-103|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01597401
7400374003AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast CancerRecruitingNo Results AvailableAdvanced Metastatic Breast CancerDrug: AZD2014|Drug: Fulvestranthttps://ClinicalTrials.gov/show/NCT01597388
7400474004Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)RecruitingNo Results AvailableAsthma, Aspirin-Induced|Aspirin Exacerbated AsthmaDrug: Prasugrelhttps://ClinicalTrials.gov/show/NCT01597375
7400574005Three Laparoscopic Access TechniquesCompletedNo Results AvailableBenign Gynecological PathologyProcedure: laparoscopy|Procedure: Laparoscopy|Procedure: Laparoscopy|Procedure: Laparoscopyhttps://ClinicalTrials.gov/show/NCT01597362
7400674006Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract InfectionCompletedNo Results AvailableAcute CoughDrug: FP01https://ClinicalTrials.gov/show/NCT01597349
7400774007Treatment of Abdominal Abscesses With or Without FibrinolysisCompletedNo Results AvailableAbdominal Abscess|Tissue Plasminogen ActivatorProcedure: Tissue plasminogen activator abscess flush|Procedure: Saline flush of abscesshttps://ClinicalTrials.gov/show/NCT01597336
7400874008Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin TextureRecruitingNo Results AvailableSkin Texture Irregularities|Facial Skin Wrinkleshttps://ClinicalTrials.gov/show/NCT01597323
7400974009Dexpramipexole and Warfarin Drug Drug Interaction (DDI) StudyCompletedNo Results AvailableHealthy VolunteersDrug: Warfarin|Drug: Dexpramipexolehttps://ClinicalTrials.gov/show/NCT01597310
7401074010Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.CompletedNo Results AvailableMultiple SclerosisDrug: BIIB041 (PR Fampridine)|Other: Placebohttps://ClinicalTrials.gov/show/NCT01597297

* Görseller ve İçerik tekif hakkına sahip olabilir